Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
申请公布号
WO2007095156(A3)
申请公布日期
2007.12.21
申请号
WO2007US03649
申请日期
2007.02.12
申请人
MPEX PHARMACEUTICALS, INC.;SURBER, MARK;BOSTIAN, KEITH;LOMOVSKAYA, OLGA;GRIFFITH, DAVID;DUDLEY, MIKE
发明人
SURBER, MARK;BOSTIAN, KEITH;LOMOVSKAYA, OLGA;GRIFFITH, DAVID;DUDLEY, MIKE